20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In Sweden, approximately 6% of children and 10% of adults suffer from house dust mite (HDM) allergy with symptoms of allergic rhinitis and allergic asthma. Treatment is aimed at reducing HDM exposure and to control the symptoms of allergic rhinitis and allergic asthma by symptom-relieving pharmacotherapy. This pharmacotherapy is often effective, but some patients remain inadequately controlled. For these patients, allergy immunotherapy (AIT, subcutaneous or sublingual) with repeated administration of HDM allergen should be considered. The objective of this study was to compare the costs for sublingual AIT (SLIT; SQ(®) SLIT-tablet) to the costs for subcutaneous AIT (SCIT; SQ(®) SCIT) for the treatment of HDM allergy in a cost-minimisation analysis (CMA).

          Related collections

          Author and article information

          Journal
          Clin Drug Investig
          Clinical drug investigation
          Springer Nature
          1179-1918
          1173-2563
          Jun 2017
          : 37
          : 6
          Affiliations
          [1 ] Nordic Health Economics AB, Gothenburg, Sweden. ase.bjorstad@nordichealtheconomics.se.
          [2 ] Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
          [3 ] Department of Ear, Nose and Throat Diseases, Karolinska University Hospital, Stockholm, Sweden.
          [4 ] ALK, Hørsholm, Denmark.
          [5 ] ALK, Kungsbacka, Sweden.
          Article
          10.1007/s40261-017-0516-1
          10.1007/s40261-017-0516-1
          28326466
          4c23b4d9-97c0-405a-8442-c62423c080f5
          History

          Comments

          Comment on this article